Form 8-K - Current report:
SEC Accession No. 0001104659-21-119858
Filing Date
2021-09-28
Accepted
2021-09-27 18:16:23
Documents
14
Period of Report
2021-09-27
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124617d4_8k.htm   iXBRL 8-K 31212
2 EXHIBIT 99.1 tm2124617d4_ex99-1.htm EX-99.1 17017
6 GRAPHIC tm2124617d4_ex99-1img01.jpg GRAPHIC 4409
  Complete submission text file 0001104659-21-119858.txt   238339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20210927.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20210927_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20210927_pre.xml EX-101.PRE 22723
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2124617d4_8k_htm.xml XML 3747
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 211283086
SIC: 2834 Pharmaceutical Preparations